- Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes
- Browse: 121 Download: 290 Issue Date: 2026-10-21
- Gut microbiome in patients with cirrhosis and clinically significant portal hypertension: A pilot study
- Browse: 108 Download: 333 Issue Date: 2026-10-21
- Autoimmune hepatitis in the context of systemic lupus erythematosus: A narrative review of overlap syndrome and lupus-associated hepatitis
- Browse: 106 Download: 238 Issue Date: 2026-10-21
- Imbalance of the coagulation-anticoagulation-fibrinolytic system: Pathogenesis and therapeutic approaches in progressive liver injury
- Browse: 98 Download: 236 Issue Date: 2026-10-21
- Hyperammonemia as a potential contributor to fatigue in metabolic dysfunction-associated steatotic liver disease: A mechanistic review
- Browse: 102 Download: 254 Issue Date: 2026-10-21
- Splenic stiffness measurement to predict decompensation in compensated advanced chronic liver disease
- Browse: 151 Download: 533 Issue Date: 2026-09-17
- From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
- Browse: 115 Download: 397 Issue Date: 2026-09-17
- Hepatocellular carcinoma with obstructive jaundice: Biliary drainage and multimodal therapy
- Browse: 130 Download: 370 Issue Date: 2026-09-17
- Molecular characteristics and carcinogenic mechanisms of aflatoxin B1-associated hepatocellular carcinoma: Recent advances
- Browse: 109 Download: 407 Issue Date: 2026-09-17
- Predicting pancreatic fistula risk after splenectomy in cirrhotic splenomegaly: Surgical anatomy and implications
- Browse: 106 Download: 369 Issue Date: 2026-09-17
- Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
- Browse: 142 Download: 590 Issue Date: 2026-08-18
- Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes
- Browse: 118 Download: 738 Issue Date: 2026-08-18
- Effect of hepatic venous pressure gradient in different hepatic venous branches on assessing portal hypertension in cirrhotic patients
- Browse: 112 Download: 845 Issue Date: 2026-08-18
- Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy
- Browse: 146 Download: 434 Issue Date: 2026-08-18
- Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives
- Browse: 101 Download: 532 Issue Date: 2026-08-18
- Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
- Browse: 163 Download: 942 Issue Date: 2026-07-24
- Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
- Browse: 144 Download: 870 Issue Date: 2026-07-24
- Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
- Browse: 174 Download: 870 Issue Date: 2026-07-24
- Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
- Browse: 141 Download: 901 Issue Date: 2026-07-24
- Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
- Browse: 148 Download: 738 Issue Date: 2026-07-24